Template:Neonatal meningitis antibiotics: Difference between revisions

Latest revision as of 00:57, 20 March 2026

MRSA is uncommon in the neonate

Ampicillin 75mg/kg IV q6hrs PLUS
Cefotaxime 50mg/kg IV q6hrs OR 2.5mg/kg IV q8hrs
- Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups^[1]
If suspecting S. pneumoniae or MRSA, add standard neonatal dosing
Consider acyclovir for HSV

@@ Line 1: / Line 1: @@
 ''[[MRSA]] is uncommon in the neonate
-*[[Ampicillin]] 75mg/kg IV q6hrs '''PLUS'''
+*{{AntibioticDose|disease=Meningitis|drug=Ampicillin|dose=75mg/kg IV q6hrs|context=Neonatal|population=Pediatric}} '''PLUS'''
-*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs
+*{{AntibioticDose|disease=Meningitis|drug=Cefotaxime|dose=50mg/kg IV q6hrs|context=Neonatal|population=Pediatric}} '''OR''' {{AntibioticDose|disease=Meningitis|drug=Gentamicin|dose=2.5mg/kg IV q8hrs|context=Neonatal|population=Pediatric|link=no}}
 **Per AAP, [[ceftazidime]] 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups<ref>https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1</ref>
-*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]
+*If suspecting [[S. pneumoniae]] or [[MRSA]], add {{AntibioticDose|disease=Meningitis|drug=Vancomycin|dose=standard neonatal dosing|context=Neonatal, MRSA/Pneumococcus|population=Pediatric|link=no}}
 *Consider [[acyclovir]] for [[HSV]]